Allopurinol in Diabetes Mellitus and Multivessel Coronary Artery Disease

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT03700645

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03700645
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03700645. Randomized; no masking; primary purpose prevention. Start 2018-12-01 (anticipated); primary completion 2019-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Allopurinol in Diabetes Mellitus and Multivessel Coronary Artery Disease
Condition
Diabetes Mellitus
Condition
Ischemic Heart Disease
Condition
Multi Vessel Coronary Artery Disease
Intervention (Drug)
Allopurinol
Lead sponsor
Tel-Aviv Sourasky Medical Center (class: other government)

Record details

Record id
cardio:ct-nct03700645
Content hash
c0da34ab00c27940562298aa5919b4cabe05861254e24750ebb0e92015618417